Navigating the cause-and-effect pathways The Inflation Reduction Act of 2022 is poised to be a watershed event for the U.S. healthcare system. The ripple effects of provisions designed to transform drug price negotiations, funding sources, and patient burden will be both swift and extensive.
Inaction or avoidance will not be rewarded; organizations across the ecosystem will need to quickly separate theory from reality, and strategically prepare for significant change. | 
